Invention Grant
- Patent Title: 3-(1-oxo-4-((4-((3-oxomorpholino)methyl)benzyl)oxy)isoindolin-2-yl)piperidine-2,6-dione and isotopologues thereof
-
Application No.: US15881501Application Date: 2018-01-26
-
Publication No.: US10434095B2Publication Date: 2019-10-08
- Inventor: Hon-wah Man , Alexander L. Ruchelman
- Applicant: Celgene Corporation
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; C07D413/14 ; A61P35/00 ; A61K31/4035 ; A61K31/5377
Abstract:
Provided are 4′-arylmethoxy isoindoline compounds, e.g., 3-(1-oxo-4-((4-((3-oxomorpholino)methyl)benzyl)oxy)isoindolin-2-yl)piperidine-2,6-dione, or an isotopologue thereof, or an enantiomer or a mixture of enantiomers thereof. Pharmaceutical compositions comprising and methods for using the compounds are also disclosed.
Public/Granted literature
Information query
IPC分类:
